The Global Recombinant Therapeutic Antibodies and Proteins Market refers to the industry dedicated to creating and manufacturing biologically engineered proteins and antibodies that serve as therapeutic solutions to medical conditions. Scientists create recombinant therapeutic antibodies and proteins through laboratory processes that use genetic engineering to produce specific proteins that treat medical conditions. The market is growing because more individuals are developing chronic illnesses, creating demand for precise medical solutions and biotechnological advancements.